With Gov. Nathan Deal’s signature now fresh on Senate Bill 16, medical cannabis continues to expand in Georgia with six new illnesses added to the list of conditions eligible for treatment. Deal in 2015 signed into law Haleigh’s Hope Act, which created the Georgia Commission on Medical Cannabis to prepare comprehensive recommendations regarding the regulation of medical cannabis. The state Department of Public Health now promulgates rules and regulations for the establishment and operation of the patient registration process and dispensing of registry cards to individuals and caregivers. Physicians may “authorize,” not “prescribe,” the use of medical cannabis for certain medical conditions.
The original law made it legal for individuals with seizure disorders, Crohn’s disease, mitochondrial disease, severe or end-stage ALS, multiple sclerosis, Parkinson’s disease, sickle cell disease and cancer to possess up to 20 ounces of cannabis oil with a THC level as high as 5 percent, if approved by their physician. The new law’s list of approved conditions includes Alzheimer’s disease, AIDS, epidermolysis bullosa, autism, Tourette’s syndrome and peripheral neuropathy. With this expansion of authorized conditions, the question arises as to what impacts this may have on the workplace.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
